Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
NVIDIA
NVDA
Vale SA
VALE
KB Home
KBH
US Stock MarketDetailed Quotes
APGE Apogee Therapeutics
- 36.540
- +0.280+0.77%
Close Feb 14 16:00 ET
- 36.550
- +0.010+0.03%
Post 20:01 ET
2.14BMarket Cap-14.17P/E (TTM)
37.420High36.271Low318.58KVolume36.480Open36.260Pre Close11.68MTurnover0.85%Turnover RatioLossP/E (Static)58.51MShares72.29052wk High2.91P/B1.37BFloat Cap33.14052wk Low--Dividend TTM37.55MShs Float72.290Historical High--Div YieldTTM3.17%Amplitude14.190Historical Low36.666Avg Price1Lot Size
About Apogee Therapeutics Company
Apogee Therapeutics, Inc. operates as a biotechnology company. It offers treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications. The company was founded in 2022 and is headquartered in Waltham, MA.
Company Profile
SymbolAPGE
Company NameApogee Therapeutics
Listing DateJul 14, 2023
Issue Price17.00
Founded2022
CEODr. Michael Henderson, M.D.
MarketNASDAQ
Employees91
Fiscal Year Ends12-31
Address221 Crescent Street,Building 17, Suite 102b
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02453
Phone1-650-394-5230
Company Executives
- Name
- Position
- Salary
- Dr. Michael Henderson, M.D.
- Chief Executive Officer and Director
- 1.17M
- Jane Pritchett Henderson
- Chief Financial Officer and Chief Accounting Officer
- 1.72M
- Dr. Carl Dambkowski, M.D.
- Chief Medical Officer
- 870.83K
- Mark C. McKenna
- Chairman of the Board
- 972.87K
- Dr. Lisa L. Bollinger, M.D.
- Director
- --
- Jennifer A. Fox
- Independent Director
- 414.57K
- Tomas Kiselak
- Independent Director
- 662.82K
- Peter Harwin
- Independent Director
- 668.57K
- Nimish Shah
- Independent Director
- 664.82K
- Dr. Andrew Gottesdiener, M.D.
- Independent Director
- 666.57K
- William B.J. Jones, Jr
- Independent Director
- 411.66K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.